Essential N-3 fatty acids in cardiac insufficiency and heart failure therapy

Details for Australian Patent Application No. 2002225026 (hide)

Owner Pharmacia Italia S.p.A.

Inventors Pamparana, Franco; Stragliotto, Eduardo, Lino; Granata, Francesco

Agent Griffith Hack

Pub. Number AU-B-2002225026

PCT Pub. Number WO2002/058793

Priority MI2001A000129 25.01.01 IT

Filing date 16 January 2002

Wipo publication date 6 August 2002

Acceptance publication date 13 September 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/23 (2006.01)

A61K 31/232 (2006.01)

A61K 31/355 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002225026

13 September 2007 Application Accepted

  Published as AU-B-2002225026

13 March 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002225027-Determining the PVT properties of a hydrocarbon resevoir fluid

2002225025-Agrochemical formulations